Activated charcoal
- Generic Name
- Activated charcoal
- Brand Names
- Actidose, Insta-char
- Drug Type
- Small Molecule
- Chemical Formula
- C
- CAS Number
- 64365-11-3
- Unique Ingredient Identifier
- 2P3VWU3H10
- Background
Activated charcoal, or activated carbon, is an amorphous form of carbon prepared from incomplete combustion of carbonaceous organic matter. It is activated by an oxidizing gas flow at high temperature passed over its surface to make a fine network of pores, producing a material with large surface area and high affinity for various substances. It is used as a...
- Indication
Used as a antidote to treat poisonings following excessive oral ingestion of certain medications or poisons.
- Associated Conditions
- Abdominal Cramping, Aerophagy, Bloating, Constipation, Delayed Transit Time, Flatulence, Belching, Meteorism
- Associated Therapies
- -
A Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819
- First Posted Date
- 2011-08-04
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 26
- Registration Number
- NCT01409369
A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2011-07-08
- Last Posted Date
- 2019-01-04
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 22
- Registration Number
- NCT01389752
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas, Texas, United States
Phenytoin and Multidose Activated Charcoal
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 17
- Registration Number
- NCT00823264
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.